Table: begin end state 1 19 cytoplasmic 20 39 transmembrane 40 45 non-cytoplasmic 46 70 transmembrane 71 107 cytoplasmic 108 131 transmembrane 132 137 non-cytoplasmic 138 162 transmembrane 163 164 cytoplasmic 165 184 transmembrane 185 205 non-cytoplasmic 206 217 transmembrane 218 257 non-cytoplasmic 258 281 transmembrane 282 321 cytoplasmic 322 342 transmembrane 343 353 non-cytoplasmic 354 377 transmembrane 378 386 cytoplasmic 387 405 transmembrane 406 409 non-cytoplasmic 410 427 transmembrane 428 435 cytoplasmic 436 455 transmembrane 456 467 non-cytoplasmic 468 487 transmembrane 488 500 cytoplasmic
Input: >AZOBR_RS33690 FitnessBrowser__azobra:AZOBR_RS33690 MDLLGNLLLGLSVSLSPDNLLLCFGGALIGTLIGVLPGLGPTATVAMLLPLTFYLPPVGA LIMLAGIFYGSQYGGSATAILVNLPGESSSVVTCLDGHAMARQGRAGVALATAALASLFA GIVTTILIAVAGPPLAGVALAFGPAEYVSLMLLGLIGAVTLAHGSVVKAIAMILLGLLLS MVGTDVNSGDTRFTFGLPQLYDGIDFVPLAMGLFGLAEIISSLEQTGGAGQTTARIASLW PKREDVRQAWPATVRGTVMGALLGILPGGGATLGSFAAYSLEKKVSRHPERFGHGAIEGV AAPEAANNAASQACFIPMLSLGIPPNAIMALMIGAMTIHGITPGPQIMAKQPELFWGMIA SMLIGNVILVILNLPMIGLWVRLLRVPYGYLFPAILVFCCIGTYTLNNSGFNVLLMALFG VLGYALRKLDCEPAPLMLGFVLGPMLEENLGRALLLSGGDPTVFATRPISGSLLATAALL LILMVMPSVRRRRDEAFKDD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server